Short answer
FATE THERAPEUTICS INC (FATE) filed an 8-K current report with the SEC on June 15, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). All four proposals approved at June 12, 2026 annual meeting; three Class I directors elected through 2029.
FATE THERAPEUTICS INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- All four proposals approved at June 12, 2026 annual meeting; three Class I directors elected through 2029
- Shareholder support strongest for Ernst & Young ratification, with 86,552,927 votes for and 308,582 against
- Executive compensation approved; 59,168,689 votes for versus 1,808,669 against
- Equity plan expanded by 7,000,000 shares, enabling additional employee incentives but increasing potential dilution
- 87,134,422 shares represented out of 116,281,693 entitled to vote; 26,083,760 broker non-votes affected director, pay, and plan proposals
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other FATE THERAPEUTICS INC 8-K filings
Get the next FATE 8-K as it lands
Follow FATE for push alerts, or ask the research agent what this filing means.